First Quarter 2026 Results
Showing 272 search results
Grifols announces a next-generation automated system to enhance efficiency and flexibility in transfusion medicine laboratories
Shareholders approve key resolutions at the 2026 Annual General Shareholders’ Meeting
Grifols launches FESILTY™ (fibrinogen, human-chmt) in the U.S.
Grifols Egypt continues its growth plan through 2029 with an additional investment of €180 million
Grifols breaks ground on new manufacturing site in Spain
Grifols collaborates with CRAM on a project to bring marine conservation closer to hospitalized children
Publications
Links to our latest financial and sustainability reports and other recent publications.
Financial Report
Explore our last financial and earnings annual report.
Sustainability Report
Integrated and Sustainability Annual Report.
Position Paper
The differential value of plasma-derived medicinal products (PDMPs).
Press Kit
Explore our Press Kit to find key facts and figures on Grifols.
Media Contacts
If you're a journalist or media professional with a question, contact our media relations team.